Research Focus

Former Employee. Graduate Staff; NE Rotating Housestaff

Recent additions – View all

1. Recombinant vaccinia virus GLV-1h68 is a promising oncolytic vector in the treatment of cholangiocarcinoma

   Journal Article

   Pugalenthi, A.; Mojica, K.; Ady, J. W.; Johnsen, C.; Love, D.; Chen, N. G.; Aguilar, R. J.; Szalay, A. A.; Fong, Y.
   Cancer Gene Therapy (2015)

   Fulltext@MSK | Save
2. Oncolytic gene therapy with recombinant vaccinia strain GLV-2b372 efficiently kills hepatocellular carcinoma

   Journal Article

   Ady, J. W.; Johnsen, C.; Mojica, K.; Heffner, J.; Love, D.; Pugalenthi, A.; Belin, L. J.; Chen, N. G.; Yu, Y. A.; Szalay, A. A.; more...
   Surgery (2015)

   Fulltext@MSK | Save
3. Gene therapy using therapeutic and diagnostic recombinant oncolytic vaccinia virus GLV-1h153 for management of colorectal peritoneal carcinomatosis

   Journal Article

   Eveno, C.; Mojica, K.; Ady, J. W.; Thorek, D. L. J.; Longo, V.; Belin, L. J.; Gholami, S.; Johnsen, C.; Zanzonico, P.; Chen, N.; more...
   Surgery (2015)

   Fulltext@MSK | Save